T. Rowe Price Investment Management, Inc.

13F Holdings History for AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Symbol: AVNS on NYSE
Investment type: Equity / Common Stock - $0.01 Par Value
Latest Disclosed Ownership: 4.71M shares
Security Ownership: 10.2%

Shares, Excluding Options vs Price

Value, Excluding Options

T. Rowe Price Investment Management, Inc. ownership in AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS)

2025-10-07 - T. Rowe Price Investment Management, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.71M shares of AVANOS MEDICAL, INC. Common Stock - $0.01 Par Value (AVNS). This represents 10.2% percent ownership of the company. In their previous filing dated 2025-05-14, T. Rowe Price Investment Management, Inc. had reported owning 3.76M shares, indicating an increase of 25.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
T. Rowe Price Investment Management, Inc.	10.2%	+25%	$54.5M	4.71M	+955,918	+25.4%	$11.56	13G/A	9/30/2025	7 Oct 2025 12:51:02
T. Rowe Price Investment Management, Inc.	8.2%	+22.9%	$46.7M	3.76M	+746,264	+24.8%	$12.43	13G/A	3/31/2025	14 May 2025 10:47:09
T. Rowe Price Investment Management, Inc.	6.6%		$37.4M	3.01M			$12.43	13G/A	12/31/2024	14 Feb 2025 09:45:21

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.03%	+0.01%	$54.5M	4.71M	+716,976	+17.9%	$11.56	Q3 2025
6/30/2025	0.03%	+0%	$48.9M	4M	+238,942	+6.36%	$12.24	Q2 2025
3/31/2025	0.04%	+0.01%	$53.8M	3.76M	+746,264		$14.33	Q1 2025
12/31/2024	0.03%	+0.01%	$47.9M	3.01M	+644,267	+27.2%	$15.92	Q4 2024
9/30/2024	0.03%	+0%	$56.9M	2.37M	+149,252	+6.73%	$24.03	Q3 2024
6/30/2024	0.03%	+0%	$44.2M	2.22M	+291,026	+15.1%	$19.92	Q2 2024
3/31/2024	0.02%	+0%	$38.4M	1.93M	+70,899	+3.82%	$19.91	Q1 2024
12/31/2023	0.03%	+0%	$41.6M	1.86M	+228,785	+14.1%	$22.43	Q4 2023
9/30/2023	0.02%	+0%	$32.9M	1.63M	+117,901	+7.81%	$20.22	Q3 2023
6/30/2023	0.03%	+0%	$38.6M	1.51M	+270,471	+21.8%	$25.56	Q2 2023
3/31/2023	0.03%	+0.03%	$36.8M	1.24M	+1,238,711	NEW	$29.74	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.